2025 Dosage Packaging 
PharmaTech
JUNE 10, 2025
s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. On June 9, 2025, Secretary of Health and Human Services Robert F. June 9, 2025.
European Pharmaceutical Review
NOVEMBER 1, 2024
The worldwide pharmaceutical container packaging market is expected to rise in revenue from $104.12 billion in 2025 to approximately $174.45 billion by 2033, according to a study published by Towards Packaging. Specifically, the “high quality of biodegradable and recyclable packaging materials” are driving the market.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaTech
JUNE 19, 2025
Image Credit: © Cagkan - © Cagkan - stock.adobe.com BASF announced on June 17, 2025 that it has opened a good manufacturing practice (GMP) facility in Wyandotte, Mich. The new facility will feature state-of-the-art cleanroom packaging and high-sensitivity analytical testing capabilities. June 17, 2025. Press Release. Haigney, S.
Express Pharma
APRIL 24, 2025
Morepen Laboratories has announced the launch of four new productsTicapen, UdoFix, LycoMore, and Acifix Raftin April 2025 for the Indian market. These launches form part of Morepens broader strategy to enhance its finished dosages segment while leveraging its internal research and development (R&D) capabilities.
Express Pharma
JULY 3, 2024
CPHI Europe, reportedly, the world’s largest pharmaceutical event, will return to Messe Frankfurt from October 28-30, 2025. The event will gather the entire supply chain, including ingredients, finished dosages, machinery, bio, and packaging. CPHI events highlight industry trends, with analysts predicting growth in 2025.
PharmaTech
JUNE 19, 2025
European geopolitical shifts In two installments of Pharmaceutical Technology ®’s “Industry Outlook 2025” series, Alexander Seyf, CEO and co-founder of Autolomous, and Edwin Stone, CEO of Cellular Origins, discussed European political impacts on the pharmaceutical industry at large, and the pharma supply chain in particular. June 12, 2025.
FDA Law Blog: Biosimilars
JUNE 25, 2025
By Riëtte van Laack — On June 5, 2025, FDA announced two proposed monograph orders: 1) Proposed order OTC000038 proposes to make it easier to make (minor) changes to solid oral dosage forms not currently permitted under the specific order, and 2) proposed order OTC000037 proposes to require that certain oral dosage forms, namely orally disintegrating (..)
Expert insights. Personalized for you.
85 
Let's personalize your content